Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052486

General Counsel and CCO acquired 41,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Odence-Ford Marion General Counsel and CCO 2024-12-23 Grant or award +41,408 68,638 D
Derivatives
Odence-Ford Marion General Counsel and CCO 2024-12-23 Grant or award · Stock Option +77,742 77,742 D
Loading xslF345X05/wk-form4_1735326521.xml…